Sanofi, AZ, Lilly and more win business in China's expanded cut-price purchase program

Good news for multinational drugmakers: After bracing for China’s expanded government procurement scheme and the price cuts destined to come with it, the countrywide rollout turned out to be less terrible than some had feared.